Covetrus Inc (CVET) Stock
CVET is no longer traded. Covetrus was taken private by CD&R and TPG on October 13, 2022.
Each CVET share was exchanged for $21.00 in cash. Prices on this page are historical; the last trade was October 12, 2022 at $20.99.
Covetrus stock price history
CVET final trading statistics
- Final close
- $20.99
- Final trading day
- Oct 12, 2022
- Market cap at delisting
- $2.94B
- Shares outstanding
- 140.12M
- Final 52-week range
- $13.39 – $21.20
- Avg. volume (final 3 mo.)
- 1,306,616
- All-time high (split-adj.)
- $46.19 · Feb 2019
- All-time low (split-adj.)
- $5.64 · Mar 2020
- Return since IPO
- -50.0%
- Beta
- 1.51
- Book value / share
- $10.76
- Price / book
- 1.95
Covetrus annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $4.58B | -$54.0M | $0.96 |
| FY2020 | $4.34B | -$19.0M | $0.92 |
| FY2019 | $3.98B | -$1.0B | $0.61 |
| FY2018 | $3.78B | $100.9M | $2.19 |
| FY2017 | $3.58B | $64.4M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Covetrus Inc
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
Covetrus stock FAQ
What happened to Covetrus stock?
Covetrus was taken private by CD&R and TPG on October 13, 2022. Shareholders received $21.00 in cash for each share. CVET stock stopped trading on the Nasdaq, with a final close of $20.99 on October 12, 2022.
What did Covetrus shareholders receive?
Each CVET share was converted into $21.00 in cash. The deal was valued at about $4 billion.
Is CVET stock still trading?
No. CVET was delisted from the Nasdaq on October 13, 2022 and no longer trades on a U.S. exchange.
What was the last price of CVET stock?
CVET closed at $20.99 on its final trading day, October 12, 2022, for a market value of about $2.94B.
What were Covetrus's revenue and earnings in its last full fiscal year?
Covetrus reported revenue of $4.58B and net income of -$54.0M in fiscal 2021, its last full year as a public company.
When did Covetrus go public?
Covetrus Inc stock began trading on February 5, 2019.